Literature DB >> 4964015

Factors involved in growth-inhibition of mycoplasma by immune serum.

S Riggs, J T Sharp, R R Carpenter.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 4964015     DOI: 10.1111/j.1749-6632.1967.tb27725.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

2.  Heat lability of rabbit anti-Mycoplasma pneumoniae serum.

Authors:  L H Coleman; R J Lynn
Journal:  Antonie Van Leeuwenhoek       Date:  1972       Impact factor: 2.271

3.  Diagnostic serology inhuman mycoplasmas.

Authors:  K K Sethi
Journal:  Infection       Date:  1973       Impact factor: 3.553

4.  Nature of the serum heat-labile accessory factor involved in the metabolic inhibition of Mycoplasma pneumoniae.

Authors:  L H Coleman; R J Lynn; R A Patrick
Journal:  Antonie Van Leeuwenhoek       Date:  1974       Impact factor: 2.271

5.  Immunoelectrophoretic analysis of Mycoplasma mycoides var. mycoides.

Authors:  S S Stone; S Razin
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

6.  Detection and characterization of defective mycoplasmacidal antibody produced by rodents against Mycoplasma arthritidis.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

7.  Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components.

Authors:  I Dörner; H Brunner; H G Schiefer; H J Wellensiek
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.